ClinConnect ClinConnect Logo
Search / Trial NCT06747546

Research on Circulation Management Strategy Based on Oxygen Metabolism Balance After CHD Surgery

Launched by CHILDREN'S HOSPITAL OF FUDAN UNIVERSITY · Dec 18, 2024

Trial Information

Current as of June 26, 2025

Enrolling by invitation

Keywords

ClinConnect Summary

This study firstly offered a specialized treatment strategy for children, particularly those who have undergone cardiopulmonary bypass surgery, that uses tailored parallel control and is independent of absolute oxygen supply and consumption characteristics.In addition, this study seeks to investigate the correlation between oxygen supply and consumption following pediatric cardiopulmonary bypass surgery and to assess the clinical utility of a goal-directed strategy concerning cardiac function recovery (ICON, echocardiography, myocardial markers) and outcomes (incidence of low cardiac output...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1.Body weight \> 2.5kg;
  • 2.Preoperative oxygen saturation \>80%;
  • 3.Biventricular radical surgery with cardiopulmonary bypass.
  • Exclusion Criteria:
  • 1. Complicated with functional single ventricle and atrial isomerism;
  • 2.Complicated with liver, kidney, lung, brain and other vital organ diseases;
  • 3.History of rescue before operation;
  • 4.Palliative surgery;
  • 5.Residual deformities that significantly affected hemodynamics after operation;
  • 6.Guardians did not provide the bundle of informed consent.

About Children's Hospital Of Fudan University

The Children's Hospital of Fudan University is a leading pediatric healthcare institution in China, renowned for its commitment to advancing child health through innovative research and clinical excellence. As a prominent clinical trial sponsor, the hospital focuses on conducting high-quality, ethically-driven studies that aim to improve pediatric care and treatment outcomes. With a multidisciplinary team of experienced healthcare professionals and researchers, the hospital leverages its robust infrastructure and expertise to facilitate groundbreaking clinical trials, ensuring the safety and well-being of child participants while contributing valuable insights to the global medical community.

Locations

Minhang, Shanghai, China

Patients applied

0 patients applied

Trial Officials

Ping Ya Mi

Study Director

Children's Hospital of Fudan University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported